Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02/HO95 Study
Authors:
- 5 November 2020
- journal article
- abstracts
- Published by American Society of Hematology in Blood
- Vol. 136 (Supplement) , 37-38